EMYRIA ORD
Emyria Launches Empax Global Partnership Platform Targeting International Drug Sponsors
Emyria unveils Empax global partnership platform to link international sponsors with its clinical delivery network; Psyence signs for Phase IIb trial.
Emyria Introduces First Empax Centre to Victoria with Expanded Medibank Funding Agreement
Emyria expands Medibank funding to Victoria, unlocking Empax TRD/PTSD care at Avive Mornington Peninsula; nationwide rollout underway.
Emyria Establishes First Victorian Empax Clinic for Psychedelic-Assisted Treatments
Perth-based mental health care specialist Emyria (ASX: EMD) has secured its first Empax clinic in Victoria for the psychedelic-assisted treatment of post-traumatic stress disorder (PTSD) and treatment-resistant depression.
Emyria Commences Empax PTSD Care Program at Perth Clinic and Launches Interstate Expansion
Emyria (ASX: EMD) has begun delivering its Empax therapy for post-traumatic stress disorder (PTSD) at a Perth clinic under Australia’s first private health insurance program for psychedelic-assisted treatment. Medibank Private (ASX: MPL) is funding the program under an initial two-year agreement secured in June and will make it available to eligible health fund members. The […]